Trial Profile
Phase I study of Pemetrexed/CDGP for advanced and relapsed NSCLC after thoracic surgery.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2020
Price :
$35
*
At a glance
- Drugs Nedaplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 09 Nov 2009 New trial record